Internal Medicine
AHA Scientific Statement: Identifying best practices to improve evaluation and management of in-hospital stroke.
10 Feb, 2022 | 10:13h | UTCNews Release: Five elements to optimize treatment of in-hospital stroke – American Heart Association
Commentary on Twitter
Identifying Best Practices to Improve Evaluation and Management of In-Hospital #Stroke: A Scientific Statement From the American Heart Association #AHAJournals #ISC22 https://t.co/e6zcLMeyBZ @American_Heart @AHAScience pic.twitter.com/eBgLc7OrBK
— Stroke AHA/ASA (@StrokeAHA_ASA) February 9, 2022
Sweden ends COVID-19 testing as pandemic restrictions lifted – “only health care and elderly care workers and the most vulnerable will be entitled to free PCR testing if they are symptomatic, while the rest of the population will simply be asked to stay home if they show symptoms that could be COVID-19”.
10 Feb, 2022 | 10:07h | UTCSweden ends COVID-19 testing as pandemic restrictions lifted – Associated Press
Related:
Covid: Europe set for ‘long period of tranquillity’ in pandemic, says WHO.
As Denmark scraps COVID restrictions, WHO urges caution.
A population-based study in Qatar showed previous infection provided robust protection against reinfection with the alpha, beta, and delta variants of SARS-CoV-2 (approximately 90%). However, protection against reinfection with the omicron variant was lower (around 60%).
10 Feb, 2022 | 10:04h | UTC
Commentary on Twitter
Using a national database in Qatar, investigators found that previous #SARSCoV2 infection provided protection against reinfection that ranged from 85% to 92% for alpha, beta, and delta strains and was approx 60% protective against omicron. #COVID19 https://t.co/SGODYCmkP3 pic.twitter.com/OkgjCbyZBj
— NEJM (@NEJM) February 9, 2022
Position statement on the care of the athlete and athletic person with diabetes.
10 Feb, 2022 | 08:49h | UTC
GOLD Report 2022: Global strategy for prevention, diagnosis and management of COPD.
10 Feb, 2022 | 08:53h | UTCGOLD Report 2022: Global strategy for prevention, diagnosis and management of COPD
Systematic Review: Overuse of diagnostic testing in healthcare.
10 Feb, 2022 | 08:47h | UTCOveruse of diagnostic testing in healthcare: a systematic review – BMJ Quality & Safety
Culprit medications and risk factors associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A population-based nested case–control study.
10 Feb, 2022 | 08:42h | UTC
M-A: Time to benefit for stroke reduction after blood pressure treatment in older adults.
10 Feb, 2022 | 08:44h | UTCNews Release: New research finds more intensive blood pressure treatment may prevent strokes in older adults – Wiley
Medication management for heart failure with reduced ejection fraction: Clinical pearls for optimizing evidenced-informed therapy.
10 Feb, 2022 | 08:41h | UTCMedication management for heart failure with reduced ejection fraction – Canadian Family Physician
Short Review: Biologics for episodic and chronic migraines.
10 Feb, 2022 | 08:40h | UTCBiologics for episodic and chronic migraines – Canadian Family Physician
Opinion: Development of clinical practice guidelines ‘is a mess’.
9 Feb, 2022 | 10:16h | UTCDevelopment of clinical practice guidelines ‘is a mess’ – STAT
IDSA Updated Covid-19 Guideline now supports the use of convalescent plasma in ambulatory patients with mild to moderate COVID-19 at high risk for progression to severe disease.
9 Feb, 2022 | 10:15h | UTC
Commentary on Twitter
Update Alert: Revised recommendation on the use of #convalescentplasma in ambulatory patients w/ COVID-19 at high risk of progression to severe disease w/ no other treatment options.
📄: https://t.co/YRCxtdilXT#COVID19Guidelines @JGPharmD @adarsh_bhimraj @RMKGandhi @ShohamTxID pic.twitter.com/KpXnywH362
— IDSA (@IDSAInfo) February 8, 2022
European guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli.
9 Feb, 2022 | 10:18h | UTCRelated: IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
Though rare, Moderna Covid vaccine recipients have higher risk of heart inflammation than Pfizer.
9 Feb, 2022 | 10:06h | UTCRelated:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.
9 Feb, 2022 | 10:08h | UTCRelated:
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Commentary on Twitter
The incidence of mRNA vaccine myocarditis or pericarditis in Italy in ~3 million vaccinees age 12-39. Excess cases per 100,000; orange is 2nd dose, blue 1st dose. https://t.co/xvdV4qSdHw
Pfizer:~1/100,000 age 12-39, all 2nd dose
Moderna,: >5/100,000, age 12-39, and some 1st dose pic.twitter.com/Y1jfGrU53v— Eric Topol (@EricTopol) February 9, 2022
Australasian Consensus Guidelines for the use of antifungal agents in the hematology-oncology setting.
9 Feb, 2022 | 08:49h | UTCConsensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021
Study suggests routine cardiac screening is not needed before return to play in junior competitive athletes with mild or asymptomatic SARS-CoV-2.
9 Feb, 2022 | 10:01h | UTC
Expert Consensus: Treatment algorithm in cancer-associated thrombosis.
9 Feb, 2022 | 08:42h | UTC
Review: Supraventricular arrhythmia in pregnancy.
9 Feb, 2022 | 08:38h | UTCSupraventricular arrhythmia in pregnancy – Heart
Systematic Review: Video-observed therapy vs. directly observed therapy in patients with tuberculosis.
9 Feb, 2022 | 08:35h | UTCVideo-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis – American Journal of Preventive Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Our latest publication on @AmJPrevMed : Video-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis. Implementation of VOT improved medication adherence and bacteriological resolution compared with that of DOT in TB patients.https://t.co/xcWzrxLbHB? pic.twitter.com/4ldYJ2umd7
— Bang Truong (@bangphd_epi) December 13, 2021
Podcast: Constipation Pearls.
9 Feb, 2022 | 08:37h | UTC#314 When the Flow Won’t Go: Constipation with Dr. Iris Wang – The Curbsiders
M-A: Direct oral anticoagulants vs. warfarin in patients with atrial fibrillation.
9 Feb, 2022 | 08:29h | UTCDirect Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex – Circulation (link to abstract – $ for full-text)
M-A: Colchicine after percutaneous coronary intervention significantly reduces the risk of major adverse cardiovascular events in patients with symptomatic coronary artery disease.
9 Feb, 2022 | 08:25h | UTCRelated:
Expert Analysis | Colchicine in acute coronary syndrome: when to commence?
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Malignant pleural effusions: a review of current guidelines and practices.
9 Feb, 2022 | 08:19h | UTCRelated: Meta-Analysis: Interventions for the Management of Malignant Pleural Effusions
ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the healthcare setting.
8 Feb, 2022 | 10:18h | UTC